Suchergebnisse

PubPharm (2)

1

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189) : a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

enthalten in: The lancet / Oncology | March 2020

von Garassino, M. | Gadgeel, S. | Esteban, E. | +16

2

HER2-targeted therapy influences CTC status in metastatic breast cancer

enthalten in: Breast cancer research and treatment | 2020 May 20

von Deutsch, T. | Riethdorf, S. | Fremd, C. | +9

1
[1]